The Chemours Company
CC
$20.22
-$0.64-3.07%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.82B | 5.81B | 5.84B | 5.85B | 5.79B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.82B | 5.81B | 5.84B | 5.85B | 5.79B |
| Cost of Revenue | 4.94B | 4.90B | 4.82B | 4.79B | 4.69B |
| Gross Profit | 884.00M | 908.00M | 1.01B | 1.07B | 1.10B |
| SG&A Expenses | 533.00M | 509.00M | 598.00M | 628.00M | 602.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.58B | 5.52B | 5.53B | 5.52B | 5.40B |
| Operating Income | 244.00M | 291.00M | 309.00M | 327.00M | 385.00M |
| Income Before Tax | -299.00M | -277.00M | -210.00M | -293.00M | 37.00M |
| Income Tax Expenses | 112.00M | 110.00M | 127.00M | 136.00M | 26.00M |
| Earnings from Continuing Operations | -411.00 | -387.00 | -337.00 | -429.00 | 11.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.00 | 0.00 | -1.00M | -1.00M | -- |
| Net Income | -411.00M | -387.00M | -338.00M | -430.00M | 11.00M |
| EBIT | 244.00M | 291.00M | 309.00M | 327.00M | 385.00M |
| EBITDA | 586.00M | 642.00M | 630.00M | 642.00M | 694.00M |
| EPS Basic | -2.73 | -2.57 | -2.25 | -2.86 | 0.08 |
| Normalized Basic EPS | 0.13 | 0.25 | 0.32 | 0.40 | 0.65 |
| EPS Diluted | -2.74 | -2.58 | -2.25 | -2.87 | 0.06 |
| Normalized Diluted EPS | 0.13 | 0.25 | 0.32 | 0.40 | 0.65 |
| Average Basic Shares Outstanding | 603.66M | 617.69M | 617.05M | 616.43M | 615.61M |
| Average Diluted Shares Outstanding | 604.12M | 618.15M | 617.52M | 616.43M | 616.32M |
| Dividend Per Share | 0.26 | 0.51 | 0.68 | 0.84 | 1.00 |
| Payout Ratio | -13.14% | -20.16% | -29.29% | -28.84% | 1,345.45% |